GlassScriptPhysician profile
Thomas C Greenough
NPI 1184607665
$83,334.54
in general payments reported to CMS, 2019-2025
1 company · $3,794 in 2025
The $3,794 reported for 2025 was more than what 89% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,244 · 2020: $8,771 · 2021: $14K · 2022: $15K · 2023: $16K · 2024: $20K · 2025: $3,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Travel and Lodging: $3,554 · Education: $975 · Food and Beverage: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,014.92 |
| Travel and Lodging | $3,554.04 |
| Education | $975.00 |
| Food and Beverage | $501.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $83,334.54 | 2019-2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Greenough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.